Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> OVARIAN CANCER Latest News

MAR 31, 2014 - MedPage Today

A Must Read - Share

SGO Wrap-Up: Obesity, New Drug, No-Admit Surgery (CME/CE)

TAMPA, Fla. (MedPage Today) -- Whether obese patients with ovarian cancer should have primary debulking or neoadjuvant chemotherapy depends on "how obese" the patient is, according to a study reported here at the Society of Gynecologic Oncology meeting.

Tags: SGO Wrap-Up: Obesity, New Drug, No-Admit Surgery (CME/CE),  Ovarian Cancer Latest News